Women with PMOS should receive annual NHS checks to spot related health risks sooner, according to new draft guidance. Polyendocrine metabolic ovarian syndrome (PMOS) is a...
By Nolynn Palmer, science and partnership lead, EmaEQ and Heather Ritchie, COO, Embr Labs Summer is reminiscent of many things: the smell of sunscreen, longer evenings,...
Academics are calling for regulation banning toxic chemicals in period products as a major menstruation conference prepares to open in Brighton. The design, health and sustainability...
BACKEER and Netalis Medical have won the Women’s Health × EmbryoNet-AI Startup Competition, an international initiative designed to accelerate the development of artificial intelligence solutions in...
“She Had No Clue, Until She Did.” draws on real member experiences, from PMDD and painful periods to fertility and mental health. Cycle-tracking app Clue has...
By Somayeh McKian, a member of the clinical advisory board of Vea, the AI-powered mental health journal app The danger of efficiency culture in women’s mental...
From AI embryo analysis in India to couples fertility care launching in the US, Korea’s women’s health startups are going global, and US investors are taking...
Our sister publication Health Tech World brings its first live event to London this summer, gathering the people building, buying and regulating healthcare AI for a...
Immunotherapy may temporarily restore fertility in women with autoimmune premature ovarian insufficiency, a pilot study suggests. Three of the 10 women who received treatment later gave...
Xella Health has launched what it calls the first AI precision health platform built for the XX chromosome. The company says it aims to address a...
